Genotyping cancer-associated genes in chordoma identifies mutations in oncogenes and areas of chromosomal loss involving CDKN2A, PTEN, and SMARCB1
about
[Novel molecular aspects of chordomas].Expression of programmed cell death ligand 1 (PD-L1) and prevalence of tumor-infiltrating lymphocytes (TILs) in chordoma.Epigenetic deregulations in chordoma.Mutation Analysis of Nine Chordoma Specimens by Targeted Next-Generation Cancer Panel SequencingChordoma: an update on the pathophysiology and molecular mechanismsPrognostic and Therapeutic Markers in Chordomas: A Study of 287 Tumors.Genomic aberrations frequently alter chromatin regulatory genes in chordoma.EGFR inhibitors identified as a potential treatment for chordoma in a focused compound screen.Durable Response of Spinal Chordoma to Combined Inhibition of IGF-1R and EGFRSTAT3 Inhibition as a Therapeutic Strategy for Chordoma.Genomic and transcriptomic characterization of skull base chordoma.In Reply: Factors Predicting Recurrence After Resection of Clival Chordoma Using Variable Surgical Approaches and Radiation Modalities.HOXA7, HOXA9, and HOXA10 are differentially expressed in clival and sacral chordomas.The driver landscape of sporadic chordomaCDK4 expression in chordoma: A potential therapeutic target.U-CH17P, -M and -S, a new cell culture system for tumor diversity and progression in chordoma.
P2860
Q33275430-26DACCAF-B758-4F19-9685-9585E25083EBQ33275611-D3435184-DAAB-482D-91D3-2D5954884E06Q33275721-5F943C63-0209-441B-A2F3-4B055E6A3267Q33275749-8A9F7BB6-6E9B-41CE-9A46-A4085958DFB7Q33275783-71B79E22-E0BE-43BC-B3A7-6F4A4295B069Q33275854-48CC3BA1-70A6-4332-BEEF-DD1B125C033CQ33275983-85B5A17A-F3E8-4720-AE3B-3EB09A3A2B0FQ33276007-859BD7A1-A40F-4EE2-AAC0-A649DA4ACEC0Q33276057-EB9F36E9-949D-491E-8BC1-547E9831425DQ33276283-61A0A4FF-41EE-4568-AD27-0E232AF380B7Q33276293-F5DEB096-23B3-484C-BBAF-3696CBE77AF2Q33276444-CBA8C50A-E74E-47D5-BA43-3717E4942095Q33276506-4126E77F-D424-4225-8855-E49E61BAD180Q42376040-E77CC987-3E9D-4B5A-B954-59466220B981Q47384424-0748EF94-707A-4D62-96BB-71CC94BAD332Q47392813-790771A4-11C5-4E20-9E0D-969BE42BD64E
P2860
Genotyping cancer-associated genes in chordoma identifies mutations in oncogenes and areas of chromosomal loss involving CDKN2A, PTEN, and SMARCB1
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Genotyping cancer-associated g ...... ving CDKN2A, PTEN, and SMARCB1
@ast
Genotyping cancer-associated g ...... ving CDKN2A, PTEN, and SMARCB1
@en
Genotyping cancer-associated g ...... ing CDKN2A, PTEN, and SMARCB1.
@nl
type
label
Genotyping cancer-associated g ...... ving CDKN2A, PTEN, and SMARCB1
@ast
Genotyping cancer-associated g ...... ving CDKN2A, PTEN, and SMARCB1
@en
Genotyping cancer-associated g ...... ing CDKN2A, PTEN, and SMARCB1.
@nl
prefLabel
Genotyping cancer-associated g ...... ving CDKN2A, PTEN, and SMARCB1
@ast
Genotyping cancer-associated g ...... ving CDKN2A, PTEN, and SMARCB1
@en
Genotyping cancer-associated g ...... ing CDKN2A, PTEN, and SMARCB1.
@nl
P2093
P2860
P50
P1433
P1476
Genotyping cancer-associated g ...... ving CDKN2A, PTEN, and SMARCB1
@en
P2093
Anthony J Iafrate
Edwin Choy
Gunnlaugur P Nielsen
Jacson K Shen
Laura E MacConaill
Zhenfeng Duan
P2860
P304
P356
10.1371/JOURNAL.PONE.0101283
P407
P577
2014-07-01T00:00:00Z